Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.52
-0.24 (-4.17%)
Mar 3, 2026, 4:00 PM EST - Market closed

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $8.15M in the quarter ending September 30, 2025, with 4.42% growth. This brings the company's revenue in the last twelve months to $24.52M, down -3.91% year-over-year. In the year 2024, Foghorn Therapeutics had annual revenue of $22.60M, down -33.83%.

Revenue (ttm)
$24.52M
Revenue Growth
-3.91%
P/S Ratio
13.19
Revenue / Employee
$218,911
Employees
112
Market Cap
323.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology228.37M
Sutro Biopharma105.65M
XOMA Royalty47.11M
Neurogene925.00K
Avalo Therapeutics192.00K
Revenue Rankings

FHTX News

More News